|
FDA Clears First Drug for Parkinson's Dyskinesia - Medscape
https://www.neurotalk.org//t1.gstati...awiS2oq8x3rf5E
Medscape <img alt="" height="1" width="1"> FDA Clears First Drug for Parkinson's Dyskinesia Medscape The US Food and Drug Administration (FDA) has approved amantadine extended-release capsules (Gocovri, Adamas Pharmaceuticals Inc) for treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without ... Adamas wins its first FDA OK, setting up market launch for a reformulated Parkinson's drugEndpoints News Adamas Pharma secures approval for Parkinson's dyskinesia drugReuters Adamas Pharma shares soar on Parkinson's dyskinesia drug approvalMarketWatch Benzinga -STAT -Neurology Advisor -GlobeNewswire all 54 news articles » More... |
| All times are GMT -5. The time now is 10:38 PM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.